UB-313

UB-313 · Vaxxinity, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UB-313, covering 2025-03-12 to 2025-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants [Phase 1]

See pricing